Prostate Cancer Cell

Discovering the
future of medicine

Wistar Science: Bold. Imaginative. Inspired.

Upcoming events

125 Years of Discovery

Dmitry Gabrilovich, M.D., Ph.D.

Tumor Immunology Discoveries

In 2016, Dmitry I. Gabrilovich, M.D., Ph.D., program leader of Wistar’s Translational Tumor Immunology program, and his research team identified a marker for myeloid-derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy. The new marker has a potential clinical impact as it could be used to help direct treatment decisions and to target MDSCs for therapeutic benefit.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today